CapsuleCardiovascular
Rosuvastatin + Clopidogrel · Statin and antiplatelet combination
A capsule combining rosuvastatin, an HMG-CoA reductase inhibitor, with clopidogrel, a P2Y12 antiplatelet agent. It is used where cholesterol reduction and prevention of clot formation are both required in cardiovascular patients.
Specifications are indicative; availability, composition, pack sizes and registration requirements may vary by destination market.
01Specification
02Related